If you are experiencing problems downloading PDF or HTML fulltext, our helpdesk recommend clearing your browser cache and trying again. If you need help in clearing your cache, please click here . Still need help? Email help@ingentaconnect.com

Human immunodeficiency virus type 1 infection, clinical trials and ethics in paediatrics

$48.00 plus tax (Refund Policy)

Download / Buy Article:


Children are not little adults and questions regarding their treatment must be directly addressed to children. Phase I and II trials should closely follow those in adults, integrated by separate studies in infants. Phase III trials should be carried out in a parallel fashion, flexible enough to be modifiable according to results from larger studies in adults. On condition that study designs are ethically impeccable and are respectful of the intrinsic social weakness of children, as many children as possible should enter clinical trials to offer wide access to drugs and ensure that questions are addressed as rapidly and efficiently as possible.

Document Type: Original Article

DOI: http://dx.doi.org/10.1111/j.1651-2227.1997.tb18326.x

Affiliations: 1: Institute of Paediatrics and Obstetrics, University of Chieti, Chieti 2: Department of Paediatrics, University of Florence, Florence, Italy

Publication date: June 1, 1997

Related content



Share Content

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
Cookie Policy
ingentaconnect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more